CN112552285A - Synthesis method of 4- (2,2, 2-trichloroethyl) -beta-lactam derivative - Google Patents
Synthesis method of 4- (2,2, 2-trichloroethyl) -beta-lactam derivative Download PDFInfo
- Publication number
- CN112552285A CN112552285A CN202110090246.2A CN202110090246A CN112552285A CN 112552285 A CN112552285 A CN 112552285A CN 202110090246 A CN202110090246 A CN 202110090246A CN 112552285 A CN112552285 A CN 112552285A
- Authority
- CN
- China
- Prior art keywords
- reaction
- substituted
- alkyl
- mmol
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 title claims abstract description 32
- 238000001308 synthesis method Methods 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 105
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 22
- 150000001879 copper Chemical class 0.000 claims abstract description 11
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 239000007800 oxidant agent Substances 0.000 claims abstract description 10
- 230000001590 oxidative effect Effects 0.000 claims abstract description 7
- 230000009471 action Effects 0.000 claims abstract description 3
- -1 Hydrogen Chemical class 0.000 claims description 35
- 229960001701 chloroform Drugs 0.000 claims description 30
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical group CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 12
- 150000002431 hydrogen Chemical class 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 5
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000004185 ester group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 claims description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 2
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 claims description 2
- 229940045803 cuprous chloride Drugs 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 70
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 44
- 239000010949 copper Substances 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 22
- 239000012043 crude product Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 22
- 239000003208 petroleum Substances 0.000 description 22
- 238000003786 synthesis reaction Methods 0.000 description 22
- 238000010898 silica gel chromatography Methods 0.000 description 21
- 229940125782 compound 2 Drugs 0.000 description 18
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 17
- 238000005160 1H NMR spectroscopy Methods 0.000 description 17
- 238000005303 weighing Methods 0.000 description 12
- 150000003952 β-lactams Chemical class 0.000 description 9
- RBBJXENQWXGNST-UHFFFAOYSA-N N-quinolin-8-ylbut-3-enamide Chemical compound N1=CC=CC2=CC=CC(=C12)NC(CC=C)=O RBBJXENQWXGNST-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- ZBZJXHCVGLJWFG-UHFFFAOYSA-N trichloromethyl(.) Chemical group Cl[C](Cl)Cl ZBZJXHCVGLJWFG-UHFFFAOYSA-N 0.000 description 2
- 238000004293 19F NMR spectroscopy Methods 0.000 description 1
- QBHCDUCXRVOUCN-UHFFFAOYSA-N 2-benzyl-N-quinolin-8-ylbut-3-enamide Chemical compound N1=CC=CC2=CC=CC(=C12)NC(C(C=C)CC1=CC=CC=C1)=O QBHCDUCXRVOUCN-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- RZTNANZSMJVWAR-UHFFFAOYSA-N C=CC(CCC(C=C1)=CC=C1F)C(NC1=C2N=CC=CC2=CC=C1)=O Chemical compound C=CC(CCC(C=C1)=CC=C1F)C(NC1=C2N=CC=CC2=CC=C1)=O RZTNANZSMJVWAR-UHFFFAOYSA-N 0.000 description 1
- QCIOLZTWFGDRKZ-UHFFFAOYSA-N CC(C=CCC(NC1=C2N=CC=CC2=CC=C1)=O)C1=CC=CC=C1 Chemical compound CC(C=CCC(NC1=C2N=CC=CC2=CC=C1)=O)C1=CC=CC=C1 QCIOLZTWFGDRKZ-UHFFFAOYSA-N 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- MDIILATYPIDCQV-UHFFFAOYSA-N N-quinolin-8-ylpent-3-enamide Chemical compound N1=CC=CC2=CC=CC(=C12)NC(CC=CC)=O MDIILATYPIDCQV-UHFFFAOYSA-N 0.000 description 1
- ADLCINRDGVAUKU-UHFFFAOYSA-N N1=CC=CC2=CC=CC(=C12)NC(C(C=C)C(C)C)=O Chemical compound N1=CC=CC2=CC=CC(=C12)NC(C(C=C)C(C)C)=O ADLCINRDGVAUKU-UHFFFAOYSA-N 0.000 description 1
- AQHUQAGJIBUBHG-UHFFFAOYSA-N N1=CC=CC2=CC=CC(=C12)NC(C(C=C)C)=O Chemical compound N1=CC=CC2=CC=CC(=C12)NC(C(C=C)C)=O AQHUQAGJIBUBHG-UHFFFAOYSA-N 0.000 description 1
- OHYGZNZPKLAJSE-UHFFFAOYSA-N N1=CC=CC2=CC=CC(=C12)NC(C(C=C)CC)=O Chemical compound N1=CC=CC2=CC=CC(=C12)NC(C(C=C)CC)=O OHYGZNZPKLAJSE-UHFFFAOYSA-N 0.000 description 1
- SSCVUFQUIVCJOH-UHFFFAOYSA-N N1=CC=CC2=CC=CC(=C12)NC(C(C=C)CCC1=CC=CC=C1)=O Chemical compound N1=CC=CC2=CC=CC(=C12)NC(C(C=C)CCC1=CC=CC=C1)=O SSCVUFQUIVCJOH-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007342 radical addition reaction Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The invention relates to a preparation method of a 4- (2,2, 2-trichloroethyl) -beta-lactam derivative, which comprises the steps of reacting a substituted N-quinoline-3-butenamide derivative in chloroform at 100-120 ℃ under the action of an oxidant and a copper salt catalyst, and obtaining the 4- (2,2, 2-trichloroethyl) -beta-lactam derivative after the reaction is completed. The method can obtain various 4- (2,2, 2-trichloroethyl) -beta-lactam derivatives in high yield. The method has mild reaction conditions, simple reaction operation and post-treatment process, and is suitable for large-scale production.
Description
Technical Field
The invention relates to the technical field of preparation of organic compounds, in particular to a synthesis method of a 4- (2,2, 2-trichloroethyl) -beta-lactam derivative.
Background
Beta-lactams are an important component of the N-heterocycle and are the core backbone of many natural products and drug molecules, especially specific drugs for some antibiotics. Therefore, the synthesis of the beta-lactam derivative has important value.
To date, the synthesis of β -lactam derivatives has been mainly as follows:
the synthesis of beta-lactam derivatives is described inJ. Am. Chem. Soc, 1982, 1043233 the method is described by oxidation of the ring.J. Org. Chem. 1995, 601276 discloses a method of preparing beta-lactam derivatives by ring closure reaction by reduction.
A method for synthesizing beta-lactam by utilizing C-H bond activation and metal catalysis respectively inAngewandte Chemie,2013, 52, 13588、Angewandte Chemie 2014, 533496 andChem. Eur. J, 2014, 209530.
In 2019, the group of the inventor isChem. Common.2019,55, 10523 reported a free radical-promoted addition cyclization reaction that synthesized beta-lactams. This reaction has certain technical advantages, however, it is limited to benzyl radical promoted reactions, and it is not suitable for the synthesis of 4- (2,2, 2-trichloroethyl) - β -lactam derivatives.
In summary, the existing method for synthesizing 4- (2,2, 2-trichloroethyl) -beta-lactam derivatives generally uses very expensive raw materials, and has harsh reaction conditions and is not environment-friendly.
Disclosure of Invention
In order to overcome the defects of low yield, use of expensive raw materials, harsh reaction conditions and environmental friendliness of the 4- (2,2, 2-trichloroethyl) -beta-lactam derivative prepared by the prior art, the invention aims to provide the preparation method of the 4- (2,2, 2-trichloroethyl) -beta-lactam derivative, which has the advantages of easily available raw materials, high yield, mild reaction conditions, good universality and environmental protection.
The inventors of the present invention have found through intensive studies that 4- (2,2, 2-trichloroethyl) - β -lactam derivatives can be efficiently synthesized by initiating the trichloromethyl radical ring formation reaction, and 4- (2,2, 2-trichloroethyl) - β -lactam derivatives can be obtained in high yield by reacting substituted N-quinoline-3-butenamide derivatives with chloroform at 100 ℃ and 120 ℃ under the catalysis of copper salt and the oxidation of an oxidizing agent.
Specifically, the technical scheme of the invention is as follows:
a method for preparing a 4- (2,2, 2-trichloroethyl) -beta-lactam derivative, comprising the following steps: reacting the substituted N-quinoline-3-butenamide derivative shown in the formula (1) in chloroform at 100-120 ℃ under the action of an oxidant and a copper salt catalyst, and obtaining a 4- (2,2, 2-trichloroethyl) -beta-lactam derivative shown in the formula (2) after the reaction is completed;
wherein R is1Hydrogen, C1-C6 alkyl, phenyl or substituted phenyl;
R2and R3Independently selected from hydrogen, C1-C6 alkyl, phenyl, substituted phenyl or C1-C6 unsaturated alkyl;
and the substituent on the substituted phenyl is one or more of C1-C6 alkyl, halogen and an ester group.
In the invention, trichloromethane is used as a solvent required by the reaction and also used as a reactant.
The reaction route of the method is as follows:
the method belongs to a double-bond free radical addition cyclization reaction promoted by trichloromethyl free radical, has mild conditions and meets the requirement of green chemistry.
Further, the C1-C6 alkyl comprises one of substituted or unsubstituted straight-chain alkyl, substituted or unsubstituted branched-chain alkyl and substituted or unsubstituted cycloalkyl; wherein the substituents on the substituted linear alkyl, the substituted branched alkyl and the substituted cyclic alkyl are respectively and independently selected from alkyl and halogen.
Further, R1Is hydrogen, R3Is hydrogen or methyl, R2The alkyl group is hydrogen, unsubstituted C1-C6 linear alkyl, ester group substituted C1-C6 alkyl, allyl, benzyl, phenethyl, cyclopropylmethyl, cyclobutylmethyl, halopropyl, p-tolylethyl or halophenethyl.
Further, R2Is hydrogen, R3Is hydrogen, R1Is C1-C6 alkyl or benzyl.
Further, the oxidizing agent is di-tert-butyl peroxide (DTBP).
Further, the cupric salt catalyst is cuprous bromide (CuBr), cupric acetate (Cu (OAc)2) Cuprous chloride, copper tetraethyl-hexafluorophosphate (Cu (CH)3CN)4PF6) Copper triflate and copper bromide (CuBr)2) One or more of them. Preference is given toThe copper salt catalyst is tetraethyl nitrile copper hexafluorophosphate.
Further, the mol ratio of the substituted N-quinoline-3-butenamide derivative to the chloroform to the oxidant to the copper salt catalyst is 1: 8-12: 3-8: 0.05 to 0.2.
Preferably, the molar ratio of the substituted N-quinoline-3-butenamide derivative, the trichloromethane, the oxidizing agent and the copper salt catalyst is 1:10:6: 0.1.
Preferably, the reaction temperature is 110 ℃.
By the scheme, the invention at least has the following advantages:
1. the invention provides a brand new system, and realizes the synthesis of the 4- (2,2, 2-trichloroethyl) -beta-lactam derivative by utilizing the free radical reaction.
2. The invention uses the substituted N-quinoline-3-butene amide derivative as the starting material, and the raw materials are easy to obtain and have a plurality of varieties; the products obtained by the method of the invention are of various types, and can be directly used and can also be used for other further reactions.
3. The invention has novel reaction, simple reaction operation and post-treatment process and high yield, and is suitable for large-scale production.
The foregoing is a summary of the present invention, and in order to provide a clear understanding of the technical means of the present invention and to be implemented in accordance with the present specification, the following is a preferred embodiment of the present invention and is described in detail below.
Detailed Description
The following examples are given to further illustrate the embodiments of the present invention. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
The first embodiment is as follows: synthesis of 4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
(1) Weighing N- (8-quinolyl) -3-butenamide 1a (0.042 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 a. The isolated yield was 92%.
(2) Weighing N- (8-quinolyl) -3-butenamide 1a (0.042 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 100 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 a. The isolated yield was 83%.
(3) Weighing N- (8-quinolyl) -3-butenamide 1a (0.042 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 120 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 a. The isolated yield was 41%.
(4) Weighing N- (8-quinolyl) -3-butenamide 1a (0.042 g, 0.2 mmol) and CuBr2(0.005g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 a. The isolated yield was 62%.
(5) N- (8-quinolyl) -3-butenamide 1a (0.042 g, 0.2 mmol), Cu (OAc) were weighed2(0.004g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 a. The isolated yield was 45%.
(6) N- (8-quinolyl) -3-butenamide 1a (0.042 g, 0.2 mmol) and CuBr (0.003g, 0.02 mmol) were dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 a. The isolated yield was 50%.
2a:1H NMR (400 MHz, CDCl3) δ8.84 (dd, J = 4.1, 1.8 Hz, 1H), 8.33 (dd, J = 7.5, 1.4 Hz, 1H), 8.15 (dd, J = 8.4, 1.7 Hz, 1H), 7.60 (dd, J = 8.2, 1.3 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.42 (dd, J = 8.3, 4.1 Hz, 1H), 5.70 – 5.62 (m, 1H), 3.66 (dd, J = 14.3, 1.6 Hz, 1H), 3.57 (dd, J = 15.6, 5.2 Hz, 1H), 3.29 (dd, J = 15.6, 2.6 Hz, 1H), 2.91 (dd, J = 14.3, 10.2 Hz, 1H).; 13C NMR (101 MHz, CDCl3) δ165.82, 149.13, 140.06, 136.13, 132.86, 128.97, 126.82, 124.12, 121.58, 121.17, 96.68, 57.07, 54.23, 45.56; HRMS(ESI-TOF) Calcd for C14H12Cl3N2O [M+H]+:329.0015,found: 329.0013.
Example two: synthesis of 3-methyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
N- (8-quinolyl) -2-methyl-3-butenamide 1b (0.045 g, 0.2 mmol), Cu (CH) were weighed3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 b. The isolated yield was 59%.
2b: 1H NMR (400 MHz, CDCl3) δ 8.83 (dd, J = 4.1, 1.8 Hz, 1H), 8.33 (dd, J = 7.5, 1.4 Hz, 1H), 7.59 (dd, J = 8.2, 1.4 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.42 (dd, J = 8.4, 4.1 Hz, 1H), 5.28 (dt, J = 10.2, 2.0 Hz, 1H), 3.64 (dd, J = 14.3, 1.8 Hz, 1H), 3.47 – 3.40 (m, 1H), 2.93 (dd, J = 14.3, 10.2 Hz, 1H), 1.57 (d, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ169.54, 149.11, 140.12, 136.12, 132.77, 129.00, 126.82, 124.03, 121.54, 121.43, 96.62, 62.25, 56.97, 53.02, 13.40;HRMS Calcd for C15H14Cl3N2O [M+H] +: 343.0172, Found: 343.0169.
Example three: synthesis of 3-ethyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
N- (8-quinolyl) -2-ethyl-3-butenamide 1c (0.048 g, 0.2 mmol), Cu (CH) were weighed3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 c. The isolated yield was 61%.
2c: 1H NMR (400 MHz, CDCl3) δ8.84 (dd, J = 4.1, 1.8 Hz, 1H), 8.35 (dd, J = 7.5, 1.4 Hz, 1H), 8.14 (dd, J = 8.3, 1.7 Hz, 1H), 7.59 (dd, J = 8.2, 1.3 Hz, 1H), 7.52 (t, J = 7.8 Hz, 1H), 7.42 (dd, J = 8.3, 4.1 Hz, 1H), 5.39 (dt, J = 10.1, 2.0 Hz, 1H), 3.63 (dd, J = 14.3, 1.9 Hz, 1H), 3.46 – 3.41 (m, 1H), 2.94 (dd, J = 14.3, 10.1 Hz, 1H), 2.09 – 1.97 (m, 2H), 1.19 (t, J = 7.5 Hz, 3H);13C NMR (101 MHz, CDCl3) δ169.09, 149.12, 140.16, 136.09, 132.76, 128.99, 126.82, 123.98, 121.52, 121.35, 96.67, 59.65, 59.01, 56.97, 21.89, 11.22; HRMS Calcd for C16H16Cl3N2O [M+H] +: 357.0328, Found: 357.0321.
Example four: synthesis of 3-isopropyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
Weighing N- (8-quinolyl) -2-isopropyl-3-butenamide 1d (0.051 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 d. The isolated yield was 50%.
2d:1H NMR (400 MHz, CDCl3) δ8.84 (dd, J = 4.1, 1.6 Hz, 1H), 8.36 (dd, J = 7.5, 1.2 Hz, 1H), 8.12 (d, J = 8.2 Hz, 1H), 7.58 (d, J = 7.8 Hz, 1H), 7.51 (t, J = 7.8 Hz, 1H), 7.40 (dd, J = 8.3, 4.1 Hz, 1H), 5.45 (dt, J = 9.8, 2.0 Hz, 1H), 3.59 (dd, J = 14.4, 2.1 Hz, 1H), 3.38 (dd, J = 5.6, 2.0 Hz, 1H), 2.93 (dd, J = 14.4, 9.9 Hz, 1H), 2.35 – 2.26 (m, 1H), 1.21 (dd, J = 9.6, 6.9 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 168.40, 149.14, 140.24, 136.06, 132.65, 128.96, 126.80, 123.99, 121.50, 121.37, 96.63, 63.75, 58.41, 57.03, 28.22, 21.52, 18.91; HRMS Calcd for C17H18Cl3N2O [M+H] +: 371.0485,Found: 371.0491.
Example five: synthesis of 3-allyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
Weighing N- (8-quinolyl) -2-allyl-3-butylEnamide 1e (0.050 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 e. The isolated yield was 47%.
2e:1H NMR (400 MHz, CDCl3) δ8.84 (dd, J = 4.1, 1.8 Hz, 1H), 8.34 (dd, J = 7.5, 1.4 Hz, 1H), 8.14 (dd, J = 8.4, 1.8 Hz, 1H), 7.60 (dd, J = 8.2, 1.4 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.42 (dd, J = 8.4, 4.1 Hz, 1H), 6.04 – 5.97 (m, 1H), 5.42 (dt, J = 10.1, 2.1 Hz, 1H), 5.28 – 5.23 (m, 1H), 5.16 – 5.12 (m, 1H), 3.65 (dd, J = 14.3, 1.9 Hz, 1H), 3.56 – 3.51 (m, 1H), 2.95 (dd, J = 14.3, 10.1 Hz, 1H), 2.79 – 2.67 (m, 2H). 13C NMR (101 MHz, CDCl3) δ168.28, 149.15, 140.11, 136.08, 133.89, 132.70, 128.98, 126.81, 124.05, 121.53, 121.35, 118.12, 96.59, 59.24, 57.23, 56.84, 32.68 (s), 120.83 (s), 55.58 (s), 42.68 (s), 33.30 (s), 28.99 (s); HRMS Calcd for C17H15Cl3N2ONa [M+H]+: 391.0148, Found: 391.0148.
Example six: synthesis of 3-benzyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
N- (8-quinolyl) -2-benzyl-3-butenamide 1f (0.061 g, 0.2 mmol), Cu (CH) were weighed out3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 f. The isolated yield was 70%.
2f:1H NMR (400 MHz, CDCl3) δ8.79 (dd, J = 4.1, 1.8 Hz, 1H), 8.27 (dd, J = 7.5, 1.3 Hz, 1H), 8.14 – 8.09 (m, 1H), 7.58 (dd, J = 8.2, 1.3 Hz, 1H), 7.50 (t, J = 7.8 Hz, 1H), 7.42 – 7.35 (m, 3H), 7.32 – 7.25 (m, 2H), 7.22 – 7.17 (m, 1H), 5.40 (dt, J = 10.0, 2.0 Hz, 1H), 3.74 – 3.67 (m, 1H), 3.60 (dd, J = 14.4, 1.9 Hz, 1H), 3.37 – 3.24 (m, 2H), 2.95 (dd, J = 14.4, 10.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ168.30, 149.11, 140.19, 137.93, 136.03, 132.59, 129.51, 128.94, 128.51, 126.76, 126.64, 124.19, 121.52, 121.49, 96.51, 59.44, 58.91, 56.85, 34.73; HRMS Calcd for C21H18Cl3N2O [M+H]+: 419.0485, Found: 419.0485.
Example seven: synthesis of 3-phenethyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
1g (0.063 g, 0.2 mmol) of N- (8-quinolyl) -2-phenethyl-3-butenamide and Cu (CH) were weighed3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain 2g of the compound. The isolated yield was 61%.
2g:1H NMR (400 MHz, CDCl3) δ8.82 (dd, J = 4.1, 1.8 Hz, 1H), 8.35 (dd, J = 7.5, 1.4 Hz, 1H), 8.14 (dd, J = 8.4, 1.7 Hz, 1H), 7.60 (dd, J = 8.2, 1.4 Hz, 1H), 7.56 – 7.50 (m, 1H), 7.41 (dd, J = 8.3, 4.1 Hz, 1H), 7.28 – 7.24 (m, 4H), 7.22 – 7.15 (m, 1H), 5.39 (dt, J = 10.1, 2.0 Hz, 1H), 3.61 (dd, J = 14.3, 1.9 Hz, 1H), 3.50 – 3.42 (m, 1H), 3.11 – 3.01 (m, 1H), 2.94 – 2.84 (m, 2H), 2.38 – 2.26 (m, 2H). 13C NMR (101 MHz, CDCl3) δ168.88, 149.14, 141.38, 140.16, 136.12, 132.72, 129.00, 128.56, 128.42, 126.83, 126.03, 124.08, 121.56, 121.37, 96.59, 60.20, 57.01, 56.90, 32.98, 30.74; HRMS Calcd for C22H20Cl3N2O[M+H]+: 433.0641, Found: 433.0646.
Example eight: synthesis of 3-methylcyclopropane-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
N- (8-quinolyl) -2-methylcyclopropane-3-butenamide was weighed for 1h (0.063 g, 0.2 mmol), and Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction is finished, the crude product is purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain a compound for 2 h. The isolated yield was 50%.
2h:1H NMR (400 MHz, CDCl3) δ 8.84 (dd, J = 4.1, 1.8 Hz, 1H), 8.36 (dd, J = 7.5, 1.4 Hz, 1H), 8.14 (dd, J = 8.4, 1.7 Hz, 1H), 7.59 (dd, J = 8.2, 1.4 Hz, 1H), 7.53 (t, J = 7.8 Hz, 1H), 7.42 (dd, J = 8.3, 4.1 Hz, 1H), 5.54 (dt, J = 10.1, 2.0 Hz, 1H), 3.64 (dd, J = 14.3, 1.9 Hz, 1H), 3.58 – 3.52 (m, 1H), 2.94 (dd, J = 14.3, 10.1 Hz, 1H), 1.95 – 1.83 (m, 2H), 1.08 – 0.98 (m, 1H), 0.57 – 0.47 (m, 2H), 0.23 – 0.12 (m, 2H).13C NMR (101 MHz, CDCl3) δ169.14, 149.11, 140.17, 136.08, 132.80, 128.99, 126.83, 123.98, 121.52, 121.34, 96.72, 59.62, 58.08, 57.04, 33.62, 8.42, 5.25, 4.65; HRMS Calcd for C18H18Cl3N2O [M+H+]: 383.0485, Found: 383.0481.
Example nine: synthesis of 3-methylcyclobutane-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
Weighing N- (8-quinolyl) -2-methylcyclobutane-3-butenamide 1i (0.056 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 i. The isolated yield was 50%.
2i:1H NMR (400 MHz, CDCl3) δ 8.83 (dd, J = 4.1, 1.8 Hz, 1H), 8.34 (dd, J = 7.5, 1.4 Hz, 1H), 8.14 (dd, J = 8.4, 1.7 Hz, 1H), 7.59 (dd, J = 8.2, 1.3 Hz, 1H), 7.52 (t, J = 7.8 Hz, 1H), 7.41 (dd, J = 8.3, 4.1 Hz, 1H), 5.37 (dt, J = 10.1, 2.0 Hz, 1H), 3.60 (dd, J = 14.3, 1.9 Hz, 1H), 3.40 – 3.34 (m, 1H), 2.90 (dd, J = 14.3, 10.1 Hz, 1H), 2.75 – 2.65 (m, 1H), 2.20 – 2.12 (m, 2H), 2.09 (t, J = 7.2 Hz, 2H), 1.86 – 1.67 (m, 4H)..13C NMR (101 MHz, CDCl3) δ 169.18, 149.07, 140.12, 136.07, 132.77, 128.96, 126.81, 123.93, 121.50, 121.29, 96.70, 59.97, 57.06, 56.33, 35.95, 33.52, 29.02, 28.35, 18.44; HRMS Calcd for C19H20Cl3N2O [M+H]+: 397.0641, Found: 397.0638.
Example ten: synthesis of ethyl 2- (2-oxo-1- (8-quinolyl) -4- (2,2, 2-trichloroethyl) azetidinyl) acetate
Ethyl 3- (8-quinolinecarbonyl) -4-pentenoate 1j (0.060 g, 0.2 mmol), Cu (CH) was weighed3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of trichloromethylTo the alkane, DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction is finished, the crude product is purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain a compound 2 j. The isolated yield was 62%.
2j:1H NMR (400 MHz, CDCl3) δ 8.83 (dd, J = 4.1, 1.8 Hz, 1H), 8.30 (dd, J = 7.5, 1.4 Hz, 1H), 8.14 (dd, J = 8.4, 1.7 Hz, 1H), 7.60 (dd, J = 8.2, 1.3 Hz, 1H), 7.52 (t, J = 7.8 Hz, 1H), 7.41 (dd, J = 8.3, 4.1 Hz, 1H), 5.51 (dt, J = 9.9, 2.2 Hz, 1H), 4.19 – 4.12 (m, 2H), 3.78 – 3.73 (m, 1H), 3.69 (dd, J = 14.4, 2.0 Hz, 1H), 3.04 – 2.93 (m, 3H), 1.20 (t, J = 7.1 Hz, 3H).13C NMR (101 MHz, CDCl3)δ170.62, 167.09, 149.20, 140.21, 136.13, 132.53, 128.98, 126.79, 124.28, 121.63, 121.57, 96.40, 61.01, 59.83, 57.03, 53.51, 32.85, 14.08; HRMS Calcd for C18H17Cl3N2O3Na [M+Na]+: 437.0202, Found: 437.0201.
Example eleven: synthesis of 3- (1-chloropropyl) -4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
Weighing N- (8-quinolyl) -2- (1-chloropropane) -3-butenamide 1k (0.058 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 k. The isolated yield was 48%.
2k:1H NMR (400 MHz, CDCl3) δ8.84 (dd, J = 4.1, 1.7 Hz, 1H), 8.32 (dd, J = 7.5, 1.2 Hz, 1H), 8.15 (dd, J = 8.4, 1.7 Hz, 1H), 7.61 (dd, J = 8.2, 1.2 Hz, 1H), 7.53 (t, J = 7.9 Hz, 1H), 5.38 (dt, J = 10.1, 2.0 Hz, 1H), 3.66 – 3.59 (m, 3H), 3.50 – 3.44 (m, 1H), 2.94 (dd, J = 14.4, 10.1 Hz, 1H), 2.27 – 2.16 (m, 2H), 2.12 – 2.00 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 168.50, 149.21, 140.16, 136.14, 132.54, 128.99, 126.79, 124.23, 121.60, 121.46, 96.52, 60.22, 56.89, 56.87, 44.75, 29.71, 26.36; HRMS Calcd for C17H17Cl4N2O [M+H]+: 321.1403, Found: 405.0087.
Example twelve: synthesis of 3, 3' -dimethyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam
N- (8-quinolyl) -2, 2' -dimethyl-3-butenamide 1l (0.048 g, 0.2 mmol), Cu (CH) were weighed3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain 2l of the compound. The isolated yield was 43%.
2l: 1H NMR (400 MHz, CDCl3) δ 8.84 (dd, J = 4.2, 1.8 Hz, 1H), 8.13 (dd, J = 8.3, 1.7 Hz, 1H), 8.11 (dd, J = 7.5, 1.3 Hz, 1H), 7.65 (dd, J = 8.2, 1.3 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.42 (dd, J = 8.3, 4.2 Hz, 1H), 5.32 (dd, J= 9.4, 1.5 Hz, 1H), 3.28 (dd, J = 15.1, 1.5 Hz, 1H), 3.15 (dd, J = 15.1, 9.4 Hz, 1H), 1.59 (s, 3H), 1.52 (s, 3H).13C NMR (101 MHz, CDCl3) δ 172.94, 149.41, 141.43, 136.02, 132.17, 129.03, 126.61, 125.05, 123.52, 121.60, 96.82, 65.61, 54.19, 52.55, 22.11, 18.76; HRMS Calcd for C16H15Cl3N2ONa [M+Na]+: 379.0148, Found: 379.0149.
Example thirteen: synthesis of 3-p-toluylethyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) beta-lactam
Weighing N- (8-quinolyl) -2-p-toluenethyl-3-butenamide 1m (0.063 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 m. The isolated yield was 52%.
2m: 1H NMR (400 MHz, CDCl3) δ 8.80 (dd, J = 4.1, 1.8 Hz, 1H), 8.28 (dd, J = 7.5, 1.3 Hz, 1H), 8.11 (dd, J = 8.3, 1.7 Hz, 1H), 7.58 (dd, J = 8.2, 1.3 Hz, 1H), 7.52 – 7.48 (m, 1H), 7.39 (dd, J = 8.3, 4.1 Hz, 1H), 7.25 (d, J= 7.6 Hz, 2H), 7.09 (d, J = 7.8 Hz, 2H), 5.39 (dt, J = 10.0, 2.0 Hz, 1H), 3.71 – 3.65 (m, 1H), 3.61 (dd, J = 14.4, 1.9 Hz, 1H), 3.33 – 3.20 (m, 2H), 2.94 (dd, J = 14.4, 10.1 Hz, 1H), 2.28 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 168.41, 149.09, 140.18, 136.06, 136.02, 134.81, 132.65, 129.34, 129.18, 128.94, 126.76, 124.12, 121.50, 121.46, 96.54, 59.48, 59.04, 56.88, 34.29, 21.07; HRMS Calcd for C22H19Cl3N2ONa[M+Na]+: 455.0461, Found: 455.0461.
Example fourteen: synthesis of 3-p-fluorophenethyl-4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) beta-lactam
Weighing N- (8-quinolyl) -2-p-fluorophenethyl-3-butenamide 1N ((B))0.064 g, 0.2 mmol),Cu(CH3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 n. The isolated yield was 61%.
2n: 1H NMR (400 MHz, CDCl3) δ 8.78 (dd, J = 4.1, 1.7 Hz, 1H), 8.26 (dd, J = 7.5, 1.2 Hz, 1H), 8.12 (dd, J = 8.3, 1.7 Hz, 1H), 7.59 (dd, J = 8.1, 1.1 Hz, 1H), 7.50 (t, J = 7.9 Hz, 1H), 7.40 (dd, J = 8.3, 4.1 Hz, 1H), 7.34 – 7.30 (m, 2H), 7.00 – 6.93 (m, 2H), 5.38 (dt, J = 10.1, 2.0 Hz, 1H), 3.70 – 3.65 (m, 1H), 3.59 (dd, J = 14.4, 1.9 Hz, 1H), 3.32 (dd, J = 14.3, 5.0 Hz, 1H), 3.23 (dd, J = 14.3, 7.6 Hz, 1H), 2.95 (dd, J = 14.4, 10.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 168.08 , 161.77 (d, J = 244.3 Hz),149.14, 140.17, 136.05, 133.52, 133.49, 132.42, 131.05, 130.97, 128.95, 126.73, 124.28, 121.55, 121.50, 115.40, 115.19, 96.52, 59.16, 58.81, 56.74, 33.73. 19F NMR (377 MHz, CDCl3) δ -116.53 (s); HRMS Calcd for C21H17Cl3FN2O[M+H]+: 437.0390, Found: 437.0388.
Example fifteen: synthesis of 1- (8-quinolyl) -4- (2- (1,1, 1-trichloropropyl)) azetidin-2-one
N- (8-quinolyl) -3-pentenamide 1o (0.045 g, 0.2 mmol), Cu (CH) were weighed3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction is finished, the crude product is chromatographically separated by a silica gel column (petroleum ether: B)Ethyl acid = 30: 1) to yield compound 2o after purification. The isolated yield was 41%.
2o: 1H NMR (400 MHz, CDCl3) δ 8.89 (dd, J = 4.2, 1.7 Hz, 1H), 8.15 (dd, J = 8.3, 1.7 Hz, 1H), 7.89 (dd, J = 7.4, 1.3 Hz, 1H), 7.68 (dd, J = 8.2, 1.2 Hz, 1H), 7.59 – 7.50 (m, 1H), 7.43 (dd, J = 8.3, 4.2 Hz, 1H), 5.80 (ddd, J = 6.7, 5.6, 2.6 Hz, 1H), 3.64 (dd, J = 15.5, 5.5 Hz, 1H), 3.27 (dd, J = 15.5, 2.6 Hz, 1H), 3.08 (p, J = 6.8 Hz, 1H), 1.22 (d, J = 6.8 Hz, 3H).13C NMR (101 MHz, CDCl3) δ 166.29 (s), 148.92 (s), 140.72 (s), 140.58 (s), 137.37 (s), 136.09 (s), 133.51 (s), 130.38 (s), 128.99 (s), 126.73 (s), 124.08 (s), 121.62 (s), 121.37 (s), 91.01 (s), 55.89 (s), 43.04 (s), 34.93 (s), 31.09 (s); HRMS Calcd for C15H14Cl3N2O [M+H]+: 343.0172, found: 343.0168.
Example sixteen: synthesis of 1- (8-quinolyl) -4- (2- (1,1, 1-trichlorobutyl)) azetidin-2-one
Weighing N- (8-quinolyl) -3-hexenylamide 1p (0.048 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 p. The isolated yield was 33%.
2p: 1H NMR (400 MHz, CDCl3) δ 8.85 (dd, J = 4.2, 1.7 Hz, 1H), 8.16 (dd, J = 8.3, 1.7 Hz, 1H), 8.01 (dd, J = 7.5, 1.3 Hz, 1H), 7.66 (dd, J = 8.2, 1.2 Hz, 1H), 7.57 – 7.52 (m, 1H), 7.43 (dd, J = 8.3, 4.2 Hz, 1H), 5.83 (dd, J= 8.6, 4.8 Hz, 1H), 3.55 – 3.50 (m, 2H), 2.94 – 2.88 (m, 1H), 1.68 – 1.53 (m, 2H), 1.13 (t, J = 7.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 166.62, 149.19, 141.95, 136.24, 133.22, 129.10, 126.65, 125.24, 123.97, 121.51, 102.53, 62.31, 57.22, 42.94, 24.11, 14.02; HRMS Calcd for C16H16Cl3N2O [M+H]+: 357.0328, found:357.0320.
Example seventeen: synthesis of 1- (8-quinolyl) -4- (1,1, 1-trichloro-3-phenyl-2-propyl) azetidin-2-one
Weighing N- (8-quinolyl) -5-phenyl-3-hexenamide 1q (0.048 g, 0.2 mmol), Cu (CH)3CN)4PF6(0.008g, 0.02 mmol) was dissolved in 2 mL of chloroform, and DTBP (0.176 g, 1.2 mmol) was added. The mixture was heated to 110 ℃ for reaction and the reaction was followed by TLC until the reaction was complete. After the reaction, the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) to obtain compound 2 q. The isolated yield was 21%.
2q: 1H NMR (400 MHz, CDCl3) δ 8.18 (dd, J = 4.2, 1.8 Hz, 1H), 8.08 (dd, J = 8.3, 1.7 Hz, 1H), 7.89 (dd, J = 7.5, 1.3 Hz, 1H), 7.58 (dd, J = 8.2, 1.3 Hz, 1H), 7.49 – 7.42 (m, 1H), 7.37 – 7.27 (m, 4H), 7.24 – 7.19 (m, 2H), 5.83 (dt, J = 6.4, 3.3 Hz, 1H), 3.61 – 3.53 (m, 2H), 3.49 – 3.38 (m, 2H), 2.84 (dd, J = 14.7, 9.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ166.04, 148.90, 141.45, 138.55, 135.98, 133.23, 128.98, 128.84, 128.71, 126.77, 126.59, 124.76, 123.33, 121.23, 102.07, 60.87, 56.80, 41.27, 36.48; HRMS Calcd for C21H18Cl3N2O [M+H]+: 393.1191, Found: 393.1198.
In summary, the present invention discloses a method for preparing 4- (2,2, 2-trichloroethyl) -1- (8-quinolyl) -beta-lactam derivatives, which is characterized in that: dissolving copper salts such as substituted N-quinoline-3-butenamide derivatives, di-tert-butyl peroxide, copper tetranitrile hexafluorophosphate and the like in trichloromethane, reacting at 110 ℃, and preparing a plurality of 4- (2,2, 2-trichloroethyl) -beta-lactam derivatives with high yield.
The above is only a preferred embodiment of the present invention, and is not intended to limit the present invention, it should be noted that, for those skilled in the art, many modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.
Claims (9)
1. A method for preparing 4- (2,2, 2-trichloroethyl) -beta-lactam derivatives, which is characterized by comprising the following steps: reacting the substituted N-quinoline-3-butenamide derivative shown in the formula (1) in chloroform at 100-120 ℃ under the action of an oxidant and a copper salt catalyst, and obtaining a 4- (2,2, 2-trichloroethyl) -beta-lactam derivative shown in the formula (2) after the reaction is completed;
wherein R is1Hydrogen, C1-C6 alkyl, phenyl or substituted phenyl;
R2and R3Independently selected from hydrogen, C1-C6 alkyl, phenyl, substituted phenyl or C1-C6 unsaturated alkyl;
the substituent on the substituted phenyl is C1-C6 alkyl or halogen.
2. The method of claim 1, wherein: the C1-C6 alkyl comprises one of substituted or unsubstituted straight-chain alkyl, substituted or unsubstituted branched-chain alkyl and substituted or unsubstituted cycloalkyl; wherein, the substituent groups on the substituted straight-chain alkyl, the substituted branched-chain alkyl and the substituted naphthenic base are respectively and independently selected from one or more of alkyl, halogen and ester group.
3. According to the rightThe method according to claim 1, wherein: r1Is hydrogen, R3Is hydrogen or methyl, R2The alkyl group is hydrogen, unsubstituted C1-C6 linear alkyl, ester group substituted C1-C6 alkyl, allyl, benzyl, phenethyl, cyclopropylmethyl, cyclobutylmethyl, halopropyl, p-tolylethyl or halophenethyl.
4. The method of claim 1, wherein: r2Is hydrogen, R3Is hydrogen, R1Is C1-C6 alkyl or benzyl.
5. The method of claim 1, wherein: the oxidant is di-tert-butyl peroxide.
6. The method of claim 1, wherein: the copper salt catalyst is one or more of cuprous bromide, copper acetate, cuprous chloride, tetraethyl nitrile copper hexafluorophosphate, copper trifluoromethanesulfonate and copper bromide.
7. The method of claim 1, wherein: the molar ratio of the substituted N-quinoline-3-butenamide derivative to the trichloromethane to the oxidant to the copper salt catalyst is 1: 8-12: 3-8: 0.05 to 0.2.
8. The method of claim 1, wherein: the molar ratio of the substituted N-quinoline-3-butenamide derivative to the trichloromethane to the oxidant to the copper salt catalyst is 1:10:6: 0.1.
9. The method of claim 1, wherein: the reaction temperature was 110 ℃.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110090246.2A CN112552285B (en) | 2021-01-22 | 2021-01-22 | Synthesis method of 4- (2, 2-trichloroethyl) -beta-lactam derivative |
PCT/CN2021/077073 WO2022156025A1 (en) | 2021-01-22 | 2021-02-20 | SYNTHESIS METHOD FOR 4-(2,2,2-TRICHLOROETHYL)-β-LACTAM DERIVATIVE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110090246.2A CN112552285B (en) | 2021-01-22 | 2021-01-22 | Synthesis method of 4- (2, 2-trichloroethyl) -beta-lactam derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112552285A true CN112552285A (en) | 2021-03-26 |
CN112552285B CN112552285B (en) | 2024-07-23 |
Family
ID=75035735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110090246.2A Active CN112552285B (en) | 2021-01-22 | 2021-01-22 | Synthesis method of 4- (2, 2-trichloroethyl) -beta-lactam derivative |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112552285B (en) |
WO (1) | WO2022156025A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113045539A (en) * | 2021-03-30 | 2021-06-29 | 苏州大学 | Preparation method of 2- (4, 4-dichloro-1- (8-quinolyl) -2-azetidinyl) carboxylic acid ester derivative |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115925720A (en) * | 2022-12-30 | 2023-04-07 | 河南师范大学 | Quinoline cyclobutane compound and synthesis method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103524486A (en) * | 2013-09-18 | 2014-01-22 | 中国科学院昆明植物研究所 | N-quinolyl substituted beta-lactam compound, as well as pharmaceutical composition, synthetic method and application of compound |
CN109369629A (en) * | 2018-12-06 | 2019-02-22 | 苏州大学 | The preparation method of beta-lactam derivatives |
-
2021
- 2021-01-22 CN CN202110090246.2A patent/CN112552285B/en active Active
- 2021-02-20 WO PCT/CN2021/077073 patent/WO2022156025A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103524486A (en) * | 2013-09-18 | 2014-01-22 | 中国科学院昆明植物研究所 | N-quinolyl substituted beta-lactam compound, as well as pharmaceutical composition, synthetic method and application of compound |
CN109369629A (en) * | 2018-12-06 | 2019-02-22 | 苏州大学 | The preparation method of beta-lactam derivatives |
Non-Patent Citations (3)
Title |
---|
CHANGDUO PAN, CHAO WU, CHENG YUAN, JIN-TAO YU: "Cascade arylchloromethylation of unactivated alkenes for the construction of chloromethyl substituted dihydroisoquinolinones", 《TETRAHEDRON LETTERS》 * |
PENG SHI, JIE WANG, ZIXU GAN,ET AL.: "A Practical Copper-Catalyzed Approach to β-Lactams via Radical Carboamination of Alkenyl Carbonyl Compounds", 《CHEMCOMM》 * |
施鹏: "过渡金属催化下构建C-P,C-N键的自由基反应研究", 《中国优秀硕士学位论文全文数据库(电子期刊) 工程科技I辑》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113045539A (en) * | 2021-03-30 | 2021-06-29 | 苏州大学 | Preparation method of 2- (4, 4-dichloro-1- (8-quinolyl) -2-azetidinyl) carboxylic acid ester derivative |
Also Published As
Publication number | Publication date |
---|---|
WO2022156025A1 (en) | 2022-07-28 |
CN112552285B (en) | 2024-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69428280T2 (en) | METHOD FOR PRODUCING AZETIDINONES | |
CN109369629B (en) | β -lactam derivatives and process for their preparation | |
CN112552285B (en) | Synthesis method of 4- (2, 2-trichloroethyl) -beta-lactam derivative | |
EP0607952B1 (en) | Process for preparing 5-aminolevulinic acid | |
CN113717071A (en) | Preparation method of green visible light catalyzed acetamide compound | |
CN111646964A (en) | Novel method for synthesizing 2H-pyran-2-one derivative by base catalysis | |
EP0332930A2 (en) | Process for the synthesis of 1-cyclopropyl-quinolone-carboxylic acids and their derivatives | |
CN109651271B (en) | Synthetic method of 3-tert-butyl-N-methylquinoxaline-2 (1H) -ketone compound | |
CN112694430B (en) | Preparation method of 1, 5-dihydro-2H-pyrrole-2-ketone compound | |
CN115785122A (en) | Indole derivative piperidine compound and synthetic method thereof | |
KR20050009293A (en) | Compounds Useful in Preparing Camptothecin Derivatives | |
CN111233750B (en) | 3, 3-difluoro-1, 2,3, 6-tetrahydropiperidine derivative and preparation method thereof | |
CN109748809B (en) | Method for synthesizing 2-substituted amino-1, 4-naphthoquinone derivative | |
CN110092751B (en) | Synthesis method of 2-alkyl quinoline | |
CN108794396B (en) | Oxidation method of 4-oxo-2, 3-dihydroquinoline compound | |
CN107286040B (en) | Method for synthesizing colchicine | |
JPH0247990B2 (en) | ||
CN112125843B (en) | Preparation method of 3-hydroxymethyl-4-phenyl-3, 4-dihydroquinolinone compound | |
CN113248418B (en) | 3-alkynyl-2, 4-diester-based pyrrole compound and preparation method thereof | |
CN113429424B (en) | Preparation method of [1,2,4] oxadiazino indoline-3-ketone derivative | |
JPH061776A (en) | Production of substituted pyrazinecarbonitrile | |
CN110218137B (en) | Synthetic method of anthranilic aldehyde compound | |
JP4643474B2 (en) | Method for producing mono-substituted succinimide | |
CN101607923A (en) | Aromatic nitrile compounds or derivatives thereof and synthetic method thereof and application | |
CN117946104A (en) | Preparation method of iodine-mediated indolo [2,3-b ] quinoline compound in water phase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |